60 related articles for article (PubMed ID: 6899978)
21. Separation of six bovine complement components and one inactivator (1, 2).
Barta O; Nelson RA; Kuo CY
Immunol Commun; 1976; 5(1-2):75-86. PubMed ID: 950248
[TBL] [Abstract][Full Text] [Related]
22. Purification and quantitation of the components of the alternative complement pathway.
Minta JO; Gee AP
Methods Enzymol; 1983; 93():375-408. PubMed ID: 6223199
[No Abstract] [Full Text] [Related]
23. Alternative pathway of complement.
Pangburn MK
Methods Enzymol; 1988; 162():639-53. PubMed ID: 2976114
[No Abstract] [Full Text] [Related]
24. Increased ion permeability of planar lipid bilayer membranes after treatment with the C5b-9 cytolytic attack mechanism of complement.
Michaels DW; Abramovitz AS; Hammer CH; Mayer MM
Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2852-6. PubMed ID: 1066698
[TBL] [Abstract][Full Text] [Related]
25. Raji cell injury and subsequent lysis by the purified cytolytic alternative pathway of human complement.
Schreiber RD; Pangburn MK; Medicus RG; Müller-Eberhard HJ
Clin Immunol Immunopathol; 1980 Mar; 15(3):384-96. PubMed ID: 6899978
[No Abstract] [Full Text] [Related]
26. Formation and function of the classical and alternative pathways of complement.
Ogle JD; Ogle CK
Clin Physiol Biochem; 1983; 1(2-5):194-213. PubMed ID: 6241120
[No Abstract] [Full Text] [Related]
27. Activation of the alternative complement pathway.
Fearon DT
CRC Crit Rev Immunol; 1979 Nov; 1(1):1-32. PubMed ID: 162484
[No Abstract] [Full Text] [Related]
28. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
Fearon DT; Austen KF; Ruddy S
Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
[No Abstract] [Full Text] [Related]
29. Functional active complement components secreted by guinea pig peritoneal macrophages.
Brade V; Kreuzpaintner G
Immunobiology; 1982 Apr; 161(3-4):315-21. PubMed ID: 7047377
[TBL] [Abstract][Full Text] [Related]
30. [The alternative complement pathway].
Jouvin MH; Kazatchkine M
Pathol Biol (Paris); 1983 Dec; 31(10):839-46. PubMed ID: 6230588
[TBL] [Abstract][Full Text] [Related]
31. [Alternative complement pathway].
Jouvin MH; Kazatchkine M
Sem Hop; 1984 May; 60(19):1371-8. PubMed ID: 6326330
[TBL] [Abstract][Full Text] [Related]
32. [Alternative complement pathway (author's transl)].
Kazatchkine M; Nydegger U; Fearon DT
Nouv Presse Med; 1979 Jun; 8(26):2187-94. PubMed ID: 382108
[TBL] [Abstract][Full Text] [Related]
33. Complement: activation, consequences, and control.
James K
Am J Med Technol; 1982 Sep; 48(9):735-42. PubMed ID: 6215861
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxic action and other metabolic consequences of terminal complement proteins.
Shin ML; Carney DF
Prog Allergy; 1988; 40():44-81. PubMed ID: 3281171
[No Abstract] [Full Text] [Related]
35. Complement.
Müller-Eberhard HJ
Annu Rev Biochem; 1975; 44():697-724. PubMed ID: 1094920
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]